From the Journals
Turning Proteins into DNA for Ultra-Sensitive Sequencing
-
April 2, 2026
-
2 min
April 2, 2026
Excluding skin cancers, colorectal cancer is the third most common cancer diagnosed in both men and women in the United States. According to the American Cancer Society, in 2025, about 154,270 individ...
by Jo Cavallo
April 3, 2026
The CAR T-cell therapy brexucabtagene autoleucel (Tecartus) was issued full approval for adult patients with relapsed or refractory mantle cell lymphoma (MCL). The approval now includes efficacy, safe...
April 3, 2026
The addition of the selective HER2 inhibitor tucatinib to trastuzumab and pertuzumab as first-line maintenance therapy significantly prolonged investigator-assessed progression-free survival in patien...
April 3, 2026